IP Library › Granted Patent US 12,478,130
Granted Patent B2
US 12,478,130 · App. 17/636,334 · Granted Nov 25, 2025

Footwear injection mould

Inventors: Jakob Moller Hansen (Bredebro, DK); Jens Sonne Mortensen (Bredebro, DK)
Assignee: ECCO Sko A/S
A43B9/16B29D35/061B29D35/128
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,478,130
App. No.
17/636,334
Granted
Nov 25, 2025
Kind
B2
Abstract

A footwear injection mold includes a secondary injection mold defining at least part of an injection chamber. The injection chamber includes a proximal surface defining a part of a distal surface of a footwear part. The secondary injection mold includes a protrusion having an upper contacting surface, a proximal end, a primary surface faced away from the injection chamber, and a secondary surface facing the injection chamber. A normal of the upper contacting surface intersects a center point of the upper contacting surface. A protrusion plane is defined by the normal of the upper contacting surface along a width of the protrusion, and defines a boundary between a primary half and a secondary half of the protrusion, the primary half arranged between the protrusion plane and the primary surface, and the secondary half arranged between the protrusion plane and the secondary surface. A height of the proximal end of the protrusion is larger than the height of the upper contacting surface of the protrusion, relative to the normal of the upper contacting surface.

Claims (27)

1 . A footwear injection mold comprising:

a primary injection mold including:

a first side mold,

a second side mold, and

a bottom mold; and

a secondary injection mold configured to be fixed relative to the primary injection mold, the secondary injection mold defining at least part of an injection chamber for molding a footwear part, said injection chamber comprises a proximal surface defining at least part of a distal surface of the footwear part, and where the secondary injection mold comprises at least one protrusion, where the at least one protrusion comprises an upper contacting surface for contacting an upper part of a footwear, a proximal end connected to the secondary injection mold, a primary surface faced away from the injection chamber, and a secondary surface faced towards the injection chamber, and where a normal of the upper contacting surface is configured to intersect a center point of the upper contacting surface seen in a height direction, and where a protrusion plane is defined by the normal of the upper contacting surface along a width of the at least one protrusion, said protrusion plane configured to define a boundary between a primary half and a secondary half of the at least one protrusion, the primary half arranged between the protrusion plane and the primary surface and the secondary half arranged between the protrusion plane and the secondary surface, and where a height of the proximal end of the at least one protrusion is larger than a height of the upper contacting surface of the at least one protrusion, relative to the normal of the upper contacting surface,

wherein the primary half of the at least one protrusion includes a majority of a volume and/or a mass of the at least one protrusion.

2 . The footwear injection mold according to claim 1 , wherein the at least one protrusion has a length defined by a distance from the upper contacting surface to the proximal end along the normal of the upper contacting surface, and

where a difference between the height of the proximal end and said length is less than a difference between the height of the upper contacting surface and said length.

3 . The footwear injection mold according to claim 1 , wherein the height of the proximal end of the at least one protrusion is at least two times larger than the height of the upper contacting surface of the at least one protrusion, relative to the normal of the upper contacting surface.

4 . The footwear injection mold according to claim 1 , wherein the height of the proximal end of the at least one protrusion is at least three times larger than the height of the upper contacting surface of the at least one protrusion, relative to the normal of the upper contacting surface.

5 . The footwear injection mold according to claim 1 , wherein the primary half of the at least one protrusion comprises at least 50% of a volume of the at least one protrusion.

6 . The footwear injection mold according to claim 1 , wherein the secondary surface of the at least one protrusion extends from a side wall of the injection chamber to the upper contacting surface of the at least one protrusion.

7 . The footwear injection mold according to claim 1 , wherein the primary half of the at least one protrusion comprises at least 50% of a mass of the at least one protrusion.

8 . The footwear injection mold according to claim 1 , wherein the at least one protrusion includes a plurality of protrusions, and

wherein the plurality of protrusions at least partly contact the upper part of the footwear.

9 . The footwear injection mold according to claim 1 , wherein the at least one protrusion is forming a ridge at least partly contacting the upper part of the footwear, and

where the protrusion plane of the at least one protrusion is forming a continuous plane along the ridge.

10 . The footwear injection mold according to claim 1 , wherein the height of the upper contacting surface of the at least one protrusion is in excess of 2 mm.

11 . The footwear injection mold according to claim 1 , wherein the footwear injection mold is for forming a sole of the footwear.

12 . The footwear injection mold according to claim 1 , wherein the secondary injection mold comprises a polymeric material.

13 . The footwear injection mold according to claim 1 , wherein the at least one protrusion is configured to seal the injection chamber from a surrounding environment.

14 . The footwear injection mold according to claim 1 , wherein the at least one protrusion is configured to seal at least partly against an upper of a shoe, when the footwear injection mold is in a closed state.

15 . The footwear injection mold according to claim 1 , wherein the secondary injection mold is 3D printed.

16 . The footwear injection mold according to claim 1 , wherein the at least one protrusion is an integral part of the secondary injection mold.

17 . The footwear injection mold according to claim 10 , wherein the height of the upper contacting surface of the at least one protrusion is in an interval between 2 to 6 mm.

18 . The footwear injection mold according to claim 1 , wherein the primary injection mold has a higher thermal conductivity than the secondary injection mold.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2022
From: HANSEN, JAKOB MOLLER; MORTENSEN, JENS SONNE
To: ECCO SKO A/S
Reel/Frame 059041/0562 →
Priority Claims (1)
EP 19192265 · Aug 19, 2019 · regional
Continuity (1)
Related Publication 20220279893A1 · Sep 8, 2022
References Cited (105)
US 696246A · Kosters · 1902 [cited by applicant]
US 1163630A · Anderson · 1915 [cited by applicant]
US 1460358A · Krentler · 1923 [cited by applicant]
US 3314173A · Szerenyi · 1967 [cited by applicant]
US 3317940A · Herbert · 1967 [cited by applicant]
US 3319301A · Ludwig · 1967 [cited by examiner]
US 3501793A · Jonas · 1970 [cited by applicant]
US 3601831A · Daum · 1971 [cited by applicant]
US 3677679A · Christie et al. · 1972 [cited by applicant]
US 5871683A · Schaper et al. · 1999 [cited by applicant]
US 5881413A · Throneburg et al. · 1999 [cited by applicant]
US 6132663A · Johnson · 2000 [cited by applicant]
US 10293565B1 · Tran · 2019 [cited by applicant]
US 20010020222A1 · Lee et al. · 2001 [cited by applicant]
US 20050071935A1 · Shah et al. · 2005 [cited by applicant]
US 20050144034A1 · Hunter · 2005 [cited by applicant]
US 20070193068A1 · Calvano et al. · 2007 [cited by applicant]
US 20070240338A1 · Din Mahamed · 2007 [cited by applicant]
US 20090072436A1 · Dean · 2009 [cited by applicant]
US 20140277658A1 · Hanft · 2014 [cited by applicant]
US 20150298413A1 · Yang · 2015 [cited by applicant]
US 20160107391A1 · Parish et al. · 2016 [cited by applicant]
US 20160166010A1 · Bruce et al. · 2016 [cited by applicant]
US 20160360823A1 · Garbujo et al. · 2016 [cited by applicant]
US 20170095036A1 · Chen · 2017 [cited by applicant]
US 20170197345A1 · Okamoto · 2017 [cited by applicant]
US 20170202309A1 · Sterman et al. · 2017 [cited by applicant]
US 20170238659A1 · Bohnsack et al. · 2017 [cited by applicant]
US 20170239909A1 · Janney et al. · 2017 [cited by applicant]
US 20170306539A1 · Gladish · 2017 [cited by applicant]
US 20180317606A1 · Schneider · 2018 [cited by applicant]
US 20190073709A1 · Hayes · 2019 [cited by examiner]
US 20190152149A1 · Arayama · 2019 [cited by applicant]
US 20190153149A1 · Toba · 2019 [cited by applicant]
US 20190344519A1 · Lin et al. · 2019 [cited by applicant]
US 20220152962A1 · Hansen et al. · 2022 [cited by applicant]
US 20230189938A1 · Hansen · 2023 [cited by applicant]
AU 419135B2 · 1971 [cited by applicant]
AU 2016204359 · 2018 [cited by applicant]
CN 1475340A · 2004 [cited by applicant]
CN 101557925A · 2009 [cited by applicant]
CN 102414013A · 2012 [cited by applicant]
CN 102596551A · 2012 [cited by applicant]
CN 202592652U · 2012 [cited by applicant]
CN 203665868U · 2014 [cited by applicant]
CN 203697349U · 2014 [cited by applicant]
CN 105495863A · 2016 [cited by applicant]
CN 106103035A · 2016 [cited by applicant]
CN 205869403 · 2017 [cited by applicant]
CN 206170682 · 2017 [cited by applicant]
CN 206568446U · 2017 [cited by applicant]
CN 207011808U · 2018 [cited by applicant]
CN 108158134A · 2018 [cited by applicant]
CN 108673919A · 2018 [cited by applicant]
CN 213618060U · 2021 [cited by applicant]
DE 2721443A1 · 1978 [cited by applicant]
DE 10319593 · 2003 [cited by applicant]
DK 202070841A1 · 2022 [cited by applicant]
EP 0313312A2 · 1989 [cited by applicant]
EP 2110037A1 · 2009 [cited by applicant]
ES 2653974B2 · 2018 [cited by applicant]
FR 1414588A · 1965 [cited by applicant]
FR 2572324B4 · 1986 [cited by applicant]
GB 1075256A · 1967 [cited by applicant]
GB 1083199 · 1967 [cited by applicant]
GB 1197727A · 1970 [cited by applicant]
GB 1504232 · 1978 [cited by applicant]
GB 2105252 · 1983 [cited by applicant]
JP 2004090998 · 2004 [cited by applicant]
JP 2016097116A · 2016 [cited by applicant]
JP 2016198496A · 2016 [cited by applicant]
JP 2018194945 · 2018 [cited by applicant]
KR 20020096188 · 2002 [cited by applicant]
KR 100737426 · 2007 [cited by applicant]
KR 20170089514 · 2017 [cited by applicant]
TW 587014B · 2004 [cited by applicant]
WO WO02070239A1 · 2002 [cited by examiner]
WO WO2007126184 · 2007 [cited by applicant]
WO WO2008049430 · 2008 [cited by applicant]
WO WO2010136855 · 2010 [cited by applicant]
WO WO2011049306 · 2011 [cited by applicant]
WO WO2013143541 · 2013 [cited by applicant]
WO 2015033272A1 · 2015 [cited by applicant]
WO WO2016196995 · 2016 [cited by applicant]
WO 2019219532A1 · 2019 [cited by applicant]
WO 2020011514A1 · 2020 [cited by applicant]
WO 2020182260A1 · 2020 [cited by applicant]
WO WO2020182259 · 2020 [cited by applicant]
WO WO2020182261 · 2020 [cited by applicant]
Chunlei, Chai “Business Innovation Design”, Huazhong University of Science and Technology Press, Jun. 30, 2014, 4 pages. [cited by applicant]
Machine translation of Alese et al (JP 2016198496A) dated Dec. 2016. (Year: 2016). [cited by applicant]
Machine translation of Cai (CN 202592652 U) dated Dec. 2012. (Year: 2012). [cited by applicant]
Machine translation of FR 2572324 A dated May 1986. (Year: 1986). [cited by applicant]
Office Action for U.S. Appl. No. 17/438,666, mailed on Nov. 30, 2023, Hansen, “A System for Manufacturing Mould-Based Equipment for Direct Injection Production of Footwear and a Method for Manufacturing Footwear”, 9 pag… [cited by applicant]
Office Action for U.S. Appl. No. 17/438,854, mailed on Oct. 20, 2023, Mortensen, “Footwear Injection Mould”, 8 Pages. [cited by applicant]
Office Action for U.S. Appl. No. 17/612,693, mailed on Nov. 7, 2023, Jakob Moller Hansen, “Footwear Last”, 13 pages. [cited by applicant]
PCT Search Report for corresponding PCT Application No. PCT/DK2020/050235 dated Nov. 19, 2020, 4 pages. [cited by applicant]
Office Action for U.S. Appl. No. 17/438,717, mailed on Apr. 17, 2024, Hansen, “A System for Manufacturing Last-Based Equipment for Direct Injection Production of Footwear and a Method for Manufacturing Footwear,” 9 page… [cited by applicant]
Office Action for U.S. Appl. No. 17/438,778, mailed on May 16, 2024, Hansen, “A Moulding System for Direct Injection Manufacturing of Footwear,” 12 pages. [cited by applicant]
Office Action for U.S. Appl. No. 17/468,854, mailed on May 9, 2024, Mortensen, “Footwear Injection Mould,” 9 pages. [cited by applicant]
Office Action for U.S. Appl. No. 17/438,666, mailed on Jun. 6, 2024, Hansen, “A System for Manufacturing Mould-Based Equipment for Direct Injection Production of Footwear and a Method for Manufacturing Footwear ”, 5 pag… [cited by applicant]
Office Action for U.S. Appl. No. 17/926,521, mailed on Jun. 7, 2024, Hansen, “A Last for Footwear Production ”, 20 pages. [cited by applicant]
Genbao, Wen et al., “Practical Technology for Modern Injection Mold Structure Design”, China Machine Press, May 2014, 4 pages. [cited by applicant]
Office Action for U.S. Appl. No. 17/438,717, mailed on Oct. 7, 2024, Hansen, “A System for Manufacturing Last-Based Equipment for Direct Injection Production of Footwear and a Method for Manufacturing Footwear”, 7 Pages. [cited by applicant]
Office Action for U.S. Appl. No. 17/438,854, mailed on Nov. 27, 2024, Mortensen, “Footwear Injection Mould”, 10 pages. [cited by applicant]